Renal Cancer - Results from #6960

Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada - Abstract May 1, 2014

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy - Abstract May 1, 2014

Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy - Abstract May 1, 2014

Association of type of renal surgery and access to robotic technology for kidney cancer: Results from a population-based cohort - Abstract April 30, 2014

Renal adverse effects of sunitinib and its clinical significance: A single-center experience in Korea - Abstract April 30, 2014

Efficacy of pre-surgical axitinib for shrinkage of inferior vena cava thrombus in a patient with advanced renal cell carcinoma - Abstract April 30, 2014

Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma - Abstract April 29, 2014

Restaging clear cell renal carcinoma with 18F-FDG PET/CT - Abstract April 29, 2014

Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: A single institution experience - Abstract April 28, 2014

Urological tumors in renal transplantation - Abstract April 28, 2014

Case of heterochronous triple urogenital cancer (renal cell carcinoma, bladder cancer, prostatic cancer) - Abstract April 26, 2014

Warm ischemia time and postoperative complications after partial nephrectomy for renal cell carcinoma - Abstract April 26, 2014

Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: A rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors - Abstract April 26, 2014

Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma - Abstract April 25, 2014

Sarcomatoid renal cell carcinoma: Clinical outcome and survival after treatment with sunitinib - Abstract April 25, 2014

A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma - Abstract April 25, 2014

Study design and clinical evidence in mRCC: Can we save axitinib as a first-line therapy? - Abstract April 23, 2014

Therapy of mRCC beyond mTOR-inhibition in clinical practice: Results of a retrospective analysis - Abstract April 23, 2014

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial - Abstract April 23, 2014

Current patterns of presentation and treatment of renal masses: A Clinical Research Office of the Endourological Society prospective study - Abstract April 22, 2014

Page 349 of 455